(Q35030570)

5 August 2017

1 reference

title

Pharmacology, clinical efficacy, and safety of drotrecogin alfa (activated). (English)

1 reference

5 August 2017

1 reference

Maria I Rudis

1

1 reference

5 August 2017

Douglas N Fish

series ordinal

2

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

5 August 2017

1 reference

5 August 2017

volume

22

1 reference

5 August 2017

issue

12 Pt 2

1 reference

5 August 2017

page(s)

182S-195S

1 reference

Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.18.182S.33704

Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.18.182S.33704

Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: a juxtacrine system for adhesion and activation of neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.18.182S.33704

Endothelial apoptosis: could it have a role in the pathogenesis and treatment of disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.18.182S.33704

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.18.182S.33704

Activated protein C inhibits lipopolysaccharide-induced nuclear translocation of nuclear factor kappaB (NF-kappaB) and tumour necrosis factor alpha (TNF-alpha) production in the THP-1 monocytic cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.18.182S.33704

Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.18.182S.33704

Endothelial cell protein C receptor plays an important role in protein C activation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.18.182S.33704

Activated protein C versus protein C in severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.18.182S.33704

Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.18.182S.33704

Safety and dose relationship of recombinant human activated protein C for coagulopathy in severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.18.182S.33704

Efficacy and safety of recombinant human activated protein C for severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.18.182S.33704

Recombinant human activated protein C, drotrecogin alfa (activated): a novel therapy for severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.18.182S.33704

Pathophysiology of disseminated intravascular coagulation in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.18.182S.33704

Early goal-directed therapy in the treatment of severe sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.18.182S.33704

Optimal management of septic shock. Rapid recognition and institution of therapy are crucial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.18.182S.33704

Immunonutrition in patients after multiple trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.18.182S.33704

10.1592/PHCO.22.18.182S.33704

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference